 |
|
Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
Joo Young Shin, Se Joon Woo, Jeeyun Ahn, Kyu Hyung Park
Korean J Ophthalmol. 2013;27(6):425-432. Published online 2013 Nov 15 DOI: https://doi.org/10.3341/kjo.2013.27.6.425
|
|
Citations to this article as recorded by
 IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Varun Chaudhary, Frédéric Matonti, Javier Zarranz-Ventura, Michael W. Stewart
Retina.2022; 42(4): 589. CrossRef IL-33 enhances Jagged1 mediated NOTCH1 intracellular domain (NICD) deubiquitination and pathological angiogenesis in proliferative retinopathy
Deepti Sharma, Shivantika Bisen, Geetika Kaur, Eric C. Van Buren, Gadiparthi N. Rao, Nikhlesh K. Singh
Communications Biology.2022;[Epub] CrossRef Music improves the therapeutic effects of bevacizumab in rats with glioblastoma: Modulation of drug distribution to the brain
Oxana Semyachkina-Glushkovskaya, Sergey Diduk, Eroshova Anna, Dosadina Elina, Kruglov Artem, Alexander Khorovodov, Alexander Shirokov, Ivan Fedosov, Alexander Dubrovsky, Inna Blokhina, Andrey Terskov, Nikita Navolokin, Arina Evsukova, Daria Elovenko, Vikt
Frontiers in Oncology.2022;[Epub] CrossRef Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
V. G. Likhvantseva, A. S. Gevorgyan, S. G. Kapkova, E. Yu. Nekrasova
Ophthalmology in Russia.2022; 19(3): 647. CrossRef Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Mohamed A. Hamid, Nizar S. Abdelfattah, Jamshid Salamzadeh, Sahar T. A. Abdelaziz, Ahmed M. Sabry, Khaled M. Mourad, Azza A. Shehab, Baruch D. Kuppermann
International Journal of Retina and Vitreous.2021;[Epub] CrossRef Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations
Laurent Kodjikian, Mariacristina Parravano, Andreas Clemens, Rosa Dolz-Marco, Frank G. Holz, Marion R. Munk, Massimo Nicolò, Federico Ricci, Rufino Silva, S. James Talks, Rohini Kumar Verma, Javier Zarranz-Ventura, Sandrine A. Zweifel
Eye.2021; 35(8): 2119. CrossRef To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review
V. G. Likhvantseva, V. N. Trubilin, S. G. Kapkova, A. S. Gevorgyan
Ophthalmology in Russia.2021; 18(3): 389. CrossRef Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response
O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya, E.V. Bobykin
Vestnik oftal'mologii.2021; 137(5): 152. CrossRef A near-infrared laser and H2O2 activated bio-nanoreactor for enhanced photodynamic therapy of hypoxic tumors
Liming Deng, Danli Sheng, Mingzhu Liu, Lu Yang, Haitao Ran, Pan Li, Xiaojun Cai, Yang Sun, Zhigang Wang
Biomaterials Science.2020; 8(3): 858. CrossRef Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration
Izumi Yoshida, Masashi Sakamoto, Asao Sakai, Takatoshi Maeno
Journal of Ophthalmology.2020; 2020: 1. CrossRef LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Ilkay Kilic Muftuoglu, Mostafa Alam, Qi Sheng You, Raouf Gaber, Hema L. Ramkumar, Nadia Mendoza, Amit Meshi, William R. Freeman
Retina.2018; 38(3): 516. CrossRef Anatomical Characteristics of End-stage Exudative Age-related Macular Degeneration Refractory to Intravitreal Anti-vascular Endothelial Growth Factor Injection
Jun Gi Hong, Young Wook Cho, Ji Hye Jang
Journal of the Korean Ophthalmological Society.2017; 58(10): 1145. CrossRef Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Kapil G. Kapoor, Niket Todi, Alan L. Wagner
Ophthalmology and Therapy.2017; 6(1): 141. CrossRef Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration
Nathan G. Lambert, Xiaohui Zhang, Ruju R. Rai, Hironori Uehara, Susie Choi, Lara S. Carroll, Subrata K. Das, Judd M. Cahoon, Brian H. Kirk, Blaine M. Bentley, Balamurali K. Ambati
Experimental Eye Research.2016; 145: 248. CrossRef Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome
Sleiman Abou-Ltaif
Saudi Journal of Ophthalmology.2016; 30(4): 227. CrossRef Treating the untreatable patient: current options for the management of treatment‐resistant neovascular age‐related macular degeneration
Geoffrey K. Broadhead, Thomas Hong, Andrew A. Chang
Acta Ophthalmologica.2014; 92(8): 713. CrossRef
|